Lazard Asset Management
MTEM

Lazard Asset Management’s Molecular Templates, Inc. MTEM Stock Holding History

Lazard Asset Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-588
Closed -$59K – 2503
2021
Q3 		$59K Buy
+588
New +$60.6K ﹤0.01% 1609

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management's MTEM Position: Q4 2021 in Review

Lazard Asset Management sold out of Molecular Templates, Inc. (MTEM) in Q4 2021, closing a stake of 588 shares — an estimated $59K sold.

Lazard Asset Management first reported a position in MTEM in Q3 2021 and held it in 1 quarter. The position peaked at $59K in Q3 2021. 79 funds tracked by Wall St. Rank hold MTEM as of Q4 2021.

  • Lazard Asset Management reported no remaining Molecular Templates, Inc. position as of Q4 2021 after selling out during the quarter.
  • Lazard Asset Management sold 588 Molecular Templates, Inc. shares in Q4 2021, an estimated $59K.
  • Lazard Asset Management first reported a position in Molecular Templates, Inc. in Q3 2021 and held it in 1 quarter.
  • Lazard Asset Management's Molecular Templates, Inc. position peaked at $59K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2021.

Based on Lazard Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.